StockMacro
Menu

Glaukos

$237.31 +106% in 6 monthsMarket cap $14.0B

GKOS on XNYS, Health Care, Glaukos Corporation, job postings

Measures activity, not value. Not investment advice.

Revenue rose 47% over 12 months and the stock is up 149%, but the company still lost $169.8M.

  • GoodInstitutional holders rose 14% to 414 in the latest quarter
  • BadInsiders sold $72M in 90 days and bought nothing

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
1,094
Website
glaukos.com
Listed
NYSE, US
Last results
28 Oct 2026
Next results
expected around 12 Jan 2027 (an estimate: a year ago it reported on 13 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $211.0M, net income $2.0M.
Quarter to 31 Dec 2021: revenue $73.2M, net income -$21.9MQuarter to 31 Dec 2021: revenue $73.2M, net income -$21.9MQuarter to 31 Mar 2022: revenue $67.7M, net income $5.4MQuarter to 31 Mar 2022: revenue $67.7M, net income $5.4MQuarter to 30 Jun 2022: revenue $72.7M, net income -$45.5MQuarter to 30 Jun 2022: revenue $72.7M, net income -$45.5MQuarter to 30 Sep 2022: revenue $71.3M, net income -$27.6MQuarter to 30 Sep 2022: revenue $71.3M, net income -$27.6MQuarter to 31 Dec 2022: revenue $71.2M, net income -$31.5MQuarter to 31 Dec 2022: revenue $71.2M, net income -$31.5MQuarter to 31 Mar 2023: revenue $73.9M, net income -$34.6MQuarter to 31 Mar 2023: revenue $73.9M, net income -$34.6MQuarter to 30 Jun 2023: revenue $80.4M, net income -$32.8MQuarter to 30 Jun 2023: revenue $80.4M, net income -$32.8MQuarter to 30 Sep 2023: revenue $78.0M, net income -$30.4MQuarter to 30 Sep 2023: revenue $78.0M, net income -$30.4MQuarter to 31 Dec 2023: revenue $82.4M, net income -$36.8MQuarter to 31 Dec 2023: revenue $82.4M, net income -$36.8MQuarter to 31 Mar 2024: revenue $85.6M, net income -$40.8MQuarter to 31 Mar 2024: revenue $85.6M, net income -$40.8MQuarter to 30 Jun 2024: revenue $95.7M, net income -$50.5MQuarter to 30 Jun 2024: revenue $95.7M, net income -$50.5MQuarter to 30 Sep 2024: revenue $96.7M, net income -$21.4MQuarter to 30 Sep 2024: revenue $96.7M, net income -$21.4MQuarter to 31 Dec 2024: revenue $105.5M, net income -$33.6MQuarter to 31 Dec 2024: revenue $105.5M, net income -$33.6MQuarter to 31 Mar 2025: revenue $106.7M, net income -$18.1MQuarter to 31 Mar 2025: revenue $106.7M, net income -$18.1MQuarter to 30 Jun 2025: revenue $124.1M, net income -$19.7MQuarter to 30 Jun 2025: revenue $124.1M, net income -$19.7MQuarter to 30 Sep 2025: revenue $133.5M, net income -$16.2MQuarter to 30 Sep 2025: revenue $133.5M, net income -$16.2MQuarter to 31 Dec 2025: revenue $143.1M, net income -$133.7MQuarter to 31 Dec 2025: revenue $143.1M, net income -$133.7MQuarter to 31 Mar 2026: revenue $150.6M, net income -$19.8MQuarter to 31 Mar 2026: revenue $150.6M, net income -$19.8MQuarter to 30 Jun 2026: revenue $185.6M, net income -$18.4MQuarter to 30 Jun 2026: revenue $185.6M, net income -$18.4MQuarter to 30 Sep 2026: revenue $211.0M, net income $2.0MQuarter to 30 Sep 2026: revenue $211.0M, net income $2.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $211.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$211.0M$2.0M
30 Jun 2026$185.6M-$18.4M
31 Mar 2026$150.6M-$19.8M
31 Dec 2025$143.1M-$133.7M
30 Sep 2025$133.5M-$16.2M
30 Jun 2025$124.1M-$19.7M
31 Mar 2025$106.7M-$18.1M
31 Dec 2024$105.5M-$33.6M
30 Sep 2024$96.7M-$21.4M
30 Jun 2024$95.7M-$50.5M
31 Mar 2024$85.6M-$40.8M
31 Dec 2023$82.4M-$36.8M
30 Sep 2023$78.0M-$30.4M
30 Jun 2023$80.4M-$32.8M
31 Mar 2023$73.9M-$34.6M
31 Dec 2022$71.2M-$31.5M
30 Sep 2022$71.3M-$27.6M
30 Jun 2022$72.7M-$45.5M
31 Mar 2022$67.7M$5.4M
31 Dec 2021$73.2M-$21.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $690.3M $469.8M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +47% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$169.8M -$87.6M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$2.95 -$1.53
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 64.8% 76.9% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -25.5% -18.8% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -24.6% -18.6% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -22.8% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $36.0M -$27.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $162.3M $98.2M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $12.12
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 20.3 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 19.6 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
GlaukosGKOS (this company) $14.0Bloss20.3+47%-24.6%
SolventumSOLV $14.3B91.91.8-2.8%1.9%
Baxter InternationalBAX $13.1Bloss1.1+6.0%-6.0%
PenumbraPEN $12.6B80.18.1+17%10.1%
InsuletPODD $9.2B21.52.9+26%13.4%
Globus MedicalGMED $8.9B16.12.9+13%17.8%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$72.0M

bought $0, sold $72.0M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+14%

414 13F filers vs 362

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

59.3M shares held by 13F filers (30 Sep 2026) of 59.2M outstanding (26 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.6%

4.5M shares sold short (30 Oct 2026) of 59.2M outstanding (26 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.9

4.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+3.2%

4.3M shares sold short in the report before, 4.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

46%

46% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 59%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+58%

$211.0M vs $133.5M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+27%

$2.1M vs $1.6M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$63K

the 12 months before: $224K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$860K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

42

42 articles in the last 7 days; its usual week has 2.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

17×

42 articles in the last 7 days; its usual week has 2.5.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Lobbying spend $240K, 3.4× a year earlier
  • New institutional positions 84, 1.5× a year earlier

Price $237.31 on 20 Nov 2026, +149% over 12 months (12-month range $95.20 to $247.16)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $136.3M in the last 12 months (the 12 months before: -$7.7M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 6 published in the last 12 months, +20% on the 12 months before.
Revenue per quarter. Revenue $211.0M in the latest quarter, +58% on a year earlier.
Capital spending per quarter. Capital spending $2.1M in the latest quarter, +27% on a year earlier.
Institutional holders (13F filers). 414 13F filers reported holding it in the latest 13F quarter, +37% on a year earlier.
Federal obligations. Federal obligations: $31K published in the last 12 months, -85% on the 12 months before.
Lobbying spend. Lobbying spend: $860K published in the last 12 months, +192% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeMany funds opening a new position: many funds opening a new position, 84 vs usual 48 (2026-09-30); 1.5x the same period a year earlier
20 Oct 2026Sharp changeLobbying spend jump: lobbying spend jump, 240K vs usual 85K (2026-09-30); 3.4x the same period a year earlier
21 Jul 2026Sharp changeLobbying spend jump: lobbying spend jump, 240K vs usual 85K (2026-06-30); 3.4x the same period a year earlier
18 Apr 2026Sharp changeLobbying on a new issue: lobbying on a new issue: TAX (2026-03-31)
5 Jun 20248-K and other filingsDirector or officer change
5 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Apr 2024Lobbying filingnew lobbying registration (in-house)
14 Feb 2023Sharp changeShort interest spike: short interest spike, 4.4M vs usual 1.9M (2023-01-31); 2.5x the same period a year earlier
31 Jan 2023Sharp changeShort interest spike: short interest spike, 4.5M vs usual 1.8M (2023-01-13); 3.0x the same period a year earlier
17 Jan 2023Sharp changeShort interest spike: short interest spike, 4.4M vs usual 1.8M (2022-12-30); 3.7x the same period a year earlier
3 Jan 2023Sharp changeShort interest spike: short interest spike, 4.2M vs usual 1.8M (2022-12-15); 3.5x the same period a year earlier
13 Dec 2022Sharp changeShort interest spike: short interest spike, 4.1M vs usual 1.8M (2022-11-30); 3.1x the same period a year earlier
29 Nov 2022Sharp changeShort interest spike: short interest spike, 4.1M vs usual 1.8M (2022-11-15); 2.8x the same period a year earlier
15 Nov 2022Sharp changeShort interest spike: short interest spike, 4.2M vs usual 1.7M (2022-10-31); 2.9x the same period a year earlier
1 Nov 2022Sharp changeShort interest spike: short interest spike, 4.2M vs usual 1.7M (2022-10-14); 3.1x the same period a year earlier
18 Oct 2022Sharp changeShort interest spike: short interest spike, 3.9M vs usual 1.7M (2022-09-30); 2.0x the same period a year earlier
27 Sep 2022Sharp changeShort interest spike: short interest spike, 3.8M vs usual 1.7M (2022-09-15); 1.8x the same period a year earlier
1 Mar 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 9.3M vs usual 2.4M (2021-12-31); 4.3x the same period a year earlier
7 Feb 20228-K and other filingsDirector or officer change
20 Dec 20218-K and other filingsDirector or officer change
20 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Aug 2022: -$178K published
Month from 1 May 2023: -$1.2M published
Month from 1 Jun 2023: -$1.9M published
Month from 1 Jul 2023: -$10.9M published
Month from 1 Aug 2023: -$746K published
Month from 1 Oct 2023: -$3.2M published
Month from 1 Dec 2023: -$17.4M published
Month from 1 Jan 2024: -$12.8M published
Month from 1 Feb 2024: -$15.0M published
Month from 1 Mar 2024: -$2.5M published
Month from 1 Apr 2024: -$6.6M published
Month from 1 May 2024: -$1.3M published
Month from 1 Jun 2024: -$844K published
Month from 1 Jul 2024: -$273K published
Month from 1 Aug 2024: -$4.4M published
Month from 1 Sep 2024: -$392K published
Month from 1 Nov 2024: -$316K published
Month from 1 Dec 2024: -$2.3M published
Month from 1 Feb 2025: -$503K published
Month from 1 Mar 2025: -$2.7M published
Month from 1 Sep 2025: -$497K published
Month from 1 Nov 2025: -$1.8M published
Month from 1 Dec 2025: -$536K published
Month from 1 Jan 2026: -$35.4M published
Month from 1 Feb 2026: -$1.8M published
Month from 1 Mar 2026: -$590K published
Month from 1 Apr 2026: -$246K published
Month from 1 May 2026: -$5.8M published
Month from 1 Jun 2026: -$201K published
Month from 1 Jul 2026: -$4.7M published
Month from 1 Aug 2026: -$15.0M published
Month from 1 Sep 2026: -$3.0M published
Month from 1 Oct 2026: -$251K published
Month from 1 Nov 2026: -$68.7M published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 1 published
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Jan 2024: 1 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Oct 2024: 4 published
Quarter from 1 Jan 2025: 1 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 3 published
Quarter from 1 Jul 2026: 6 published
Revenue per quarter
Quarter ended 31 Dec 2021: $73.2M, 0% on a year earlier; public on 1 Mar 2022
Quarter ended 31 Mar 2022: $67.7M, -0.4% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $72.7M, -6.9% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $71.3M, -4.6% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $71.2M, -2.7% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $73.9M, +9.2% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $80.4M, +11% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $78.0M, +9.5% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $82.4M, +16% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $85.6M, +16% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $95.7M, +19% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $96.7M, +24% on a year earlier; public on 6 Nov 2024
Quarter ended 31 Dec 2024: $105.5M, +28% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $106.7M, +25% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $124.1M, +30% on a year earlier; public on 5 Aug 2025
Quarter ended 30 Sep 2025: $133.5M, +38% on a year earlier; public on 1 Nov 2025
Quarter ended 31 Dec 2025: $143.1M, +36% on a year earlier; public on 24 Feb 2026
Quarter ended 31 Mar 2026: $150.6M, +41% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $185.6M, +50% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $211.0M, +58% on a year earlier; public on 29 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $9.3M, +335% on a year earlier; public on 1 Mar 2022
Quarter ended 31 Mar 2022: $6.6M, -62% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $9.4M, -17% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $6.0M, -39% on a year earlier; public on 5 Nov 2022
Quarter ended 31 Dec 2022: $8.2M, -12% on a year earlier; public on 25 Feb 2023
Quarter ended 31 Mar 2023: $6.9M, +4.6% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $5.8M, -39% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $3.4M, -44% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $4.2M, -49% on a year earlier; public on 24 Feb 2024
Quarter ended 31 Mar 2024: $968K, -86% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $2.1M, -63% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $1.4M, -57% on a year earlier; public on 6 Nov 2024
Quarter ended 31 Dec 2024: $1.7M, -59% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $1.9M, +100% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $1.2M, -45% on a year earlier; public on 5 Aug 2025
Quarter ended 30 Sep 2025: $1.6M, +13% on a year earlier; public on 1 Nov 2025
Quarter ended 31 Dec 2025: $2.9M, +68% on a year earlier; public on 24 Feb 2026
Quarter ended 31 Mar 2026: $4.0M, +104% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $2.7M, +132% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $2.1M, +27% on a year earlier; public on 29 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 186; public on 14 Feb 2022
31 Mar 2022 report: 198; public on 16 May 2022
30 Jun 2022 report: 188; public on 15 Aug 2022
30 Sep 2022 report: 200; public on 14 Nov 2022
31 Dec 2022 report: 198; public on 14 Feb 2023
31 Mar 2023 report: 192; public on 15 May 2023
30 Jun 2023 report: 207; public on 14 Aug 2023
30 Sep 2023 report: 218; public on 14 Nov 2023
31 Dec 2023 report: 235; public on 14 Feb 2024
31 Mar 2024 report: 241; public on 15 May 2024
30 Jun 2024 report: 272; public on 14 Aug 2024
30 Sep 2024 report: 304; public on 14 Nov 2024
31 Dec 2024 report: 314; public on 14 Feb 2025
31 Mar 2025 report: 303; public on 15 May 2025
30 Jun 2025 report: 285; public on 14 Aug 2025
30 Sep 2025 report: 302; public on 14 Nov 2025
31 Dec 2025 report: 320; public on 17 Feb 2026
31 Mar 2026 report: 329; public on 15 May 2026
30 Jun 2026 report: 362; public on 14 Aug 2026
30 Sep 2026 report: 414; public on 16 Nov 2026
Federal obligations
Month from 1 Jun 2024: $256K published
Month from 1 Jul 2024: $234K published
Month from 1 Aug 2024: $11K published
Month from 1 Sep 2024: $21K published
Month from 1 Feb 2025: $21K published
Month from 1 Apr 2025: $43K published
Month from 1 May 2025: $64K published
Month from 1 Jun 2025: $64K published
Month from 1 Aug 2025: $11K published
Month from 1 Jan 2026: $21K published
Month from 1 Feb 2026: -$139K published
Month from 1 Mar 2026: $169K published
Month from 1 Sep 2026: -$21K published
Lobbying spend
Quarter from 1 Jan 2022: $50K published
Quarter from 1 Apr 2022: $20K published
Quarter from 1 Jul 2022: $20K published
Quarter from 1 Oct 2022: $20K published
Quarter from 1 Jan 2023: $20K published
Quarter from 1 Apr 2023: $20K published
Quarter from 1 Jul 2023: $20K published
Quarter from 1 Oct 2023: $20K published
Quarter from 1 Jan 2024: $20K published
Quarter from 1 Apr 2024: $20K published
Quarter from 1 Jul 2024: $90K published
Quarter from 1 Oct 2024: $90K published
Quarter from 1 Jan 2025: $90K published
Quarter from 1 Apr 2025: $65K published
Quarter from 1 Jul 2025: $70K published
Quarter from 1 Oct 2025: $70K published
Quarter from 1 Jan 2026: $80K published
Quarter from 1 Apr 2026: $280K published
Quarter from 1 Jul 2026: $240K published
Quarter from 1 Oct 2026: $260K published

What is unusual now

  • Made public in the last 90 days: it reported $240K of lobbying spend for the quarter ended 30 Sep 2026, 3.4× the same quarter last year; it also saw 84 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year. Two or more unrelated kinds of activity agreed on 17 Nov 2026.
  • Lobbying spend jump: reported $240K of lobbying spend for the quarter ended 30 Jun 2026, 3.4× the same quarter last year Public on 20 Jul 2026.
  • Many funds opening a new position: saw 84 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year Public on 16 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $136.3M in the last 12 months (the 12 months before: -$7.7M).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 10 sales, $72.0M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Nov 2026Thomas William BurnsCHAIRMAN & CEOSellplanned in advance (10b5-1); after exercising options180,000$236.89$42.6MForm 4
20 Nov 2026Alex R. ThurmanSVP & CHIEF FINANCIAL OFFICERSellplanned in advance (10b5-1); after exercising options15,000$236.92$3.6MForm 4
18 Nov 2026Joseph E GilliamPRESIDENT & COOSellplanned in advance (10b5-1); after exercising options861$250.00$215KForm 4
16 Nov 2026Joseph E GilliamPRESIDENT & COOSellplanned in advance (10b5-1); after exercising options44,917$246.32$11.1MForm 4
5 Nov 2026Gilbert H KlimanDirectorSellafter exercising options2,500$253.00$632KForm 4
3 Nov 2026Tomas NavratilCHIEF DEVELOPMENT OFFICERSellafter exercising options44,436$238.97$10.6MForm 4
7 Oct 2026Tomas NavratilCHIEF DEVELOPMENT OFFICERSellplanned in advance (10b5-1)1,527$164.45$251KForm 4
28 Sep 2026Tomas NavratilCHIEF DEVELOPMENT OFFICERSellplanned in advance (10b5-1)1,615$154.28$249KForm 4

414 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 84 opened a position, 34 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.9.3M15.8%$1.5B-216K-2.3%
Janus Henderson Group Ltd.4.6M7.82%$760.2M
Vanguard Portfolio Management LLC3.3M5.58%$542.5M-18K-0.5%
Primecap Management Co3.1M5.20%$505.1M+35K+1.2%
FMR LLC (Fidelity)2.9M4.84%$470.9M+2.5M+660%
Vanguard Capital Management LLC2.5M4.30%$418.2M-4,334-0.2%
State Street Corp2.3M3.91%$379.7M-2,954-0.1%
Millennium Management LLC1.5M2.47%$239.7M-121K-7.7%
Geode Capital Management, LLC1.4M2.45%$238.0M-14K-1.0%
Invesco Ltd.1.2M2.09%$202.8M+528K+75%

Company events

All 21 company events

Nothing in 12 months; the latest was filed 3 Dec 2024. Results releases and routine reports are left out.

FiledWhat happenedSource
3 Dec 2024Signed a major agreement8-K
5 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
7 Feb 2022Director or officer change8-K
20 Dec 2021Director or officer change8-K
9 Jun 2021Director or officer changeSame filing: shareholder vote results8-K
1 Mar 2021Director or officer change8-K
12 Jun 2020Signed a major agreementSame filing: took on new debt, sold shares privately8-K
18 Mar 2020Director or officer change8-K

Reported lobbying spend: $260K in Q3 2026, $240K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Apr 2024NewGlaukos Corporationits own lobbyistsTax Relief for American Families and Workers Act of 2023, H.R.7024TaxationFiling
15 Feb 2021NewThorn Run Partnersfor Glaukos CorporationIssues related to medical technology used for the treatment of glaucoma.MEDFiling
30 Sep 2020EndedThorn Run Partnersfor Glaukos CorporationNot statedFiling
8 Jun 2018NewJeffrey J. Kimbell & Associates, Inc.for Glaukos Corporation (Fka Avedro, Inc.)Medical Device & Pharmaceutical IssuesHealth issuesFiling
1 Dec 2015EndedJeffrey J. Kimbell & Associates, Inc.for Glaukos Corporation (Fka Avedro, Inc.)Issues related to Medical Devices and FDAHealth issuesFiling
30 Sep 2014EndedPolicy Directions Inc.for Avedro, Inc.Medical advances in opthamalogy and patient safety.MEDFiling
11 Jun 2014NewPolicy Directions Inc.for Avedro, Inc.Medical advances and patient safety.MEDFiling
1 Aug 2008EndedPaul Hastings LLPfor Glaukos CorporationAssistance with U.S. Department of Veteran Affairs on a patent license issueCopyright/patentsFiling

The 5 newest of 177 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

17 Nov 2026confirmed

Confirmed across sources Institutional holdings and Lobbying

Glaukos (GKOS): reported $240K of lobbying spend for the quarter ended 30 Sep 2026, 3.4× the same quarter last year, while it saw 84 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Lobbying: Lobbying spend jump, became public on 16 Oct 2026
  • Institutional holdings: Many funds opening a new position, became public on 16 Nov 2026
2024-09-30: $90K2024-12-31: $90K2025-03-31: $65K2025-06-30: $70K2025-09-30: $70K2025-12-31: $80K2026-03-31: $280K2026-06-30: $240K2026-09-30: $240K
The quarter ended 30 Sep 2026 against the 8 quarters before it. this quarterearliernormal: $85K
See the evidence (2 changes)

Lobbying: Lobbying spend jump became public on 16 Oct 2026

Glaukos reported $240K of lobbying spend for the quarter ended 30 Sep 2026, 3.4× the same quarter last year.

This period
$240K (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
$85K
Typical spread (median absolute deviation)
$15K
How far from its usual level
+7.0
Same quarter last year
$70K
History used
4,475 days
2024-09-30: $90K2024-12-31: $90K2025-03-31: $65K2025-06-30: $70K2025-09-30: $70K2025-12-31: $80K2026-03-31: $280K2026-06-30: $240K2026-09-30: $240K
the quarter ended 30 Sep 20268 earlier quartersnormal: $85K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Institutional holdings: Many funds opening a new position became public on 16 Nov 2026

Glaukos saw 84 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year.

This period
84 (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
48
Typical spread (median absolute deviation)
6
How far from its usual level
+4.0
Same quarter last year
55
History used
4,110 days
2024-09-30: 472024-12-31: 392025-03-31: 492025-06-30: 432025-09-30: 552025-12-31: 522026-03-31: 412026-06-30: 652026-09-30: 84
the quarter ended 30 Sep 20268 earlier quartersnormal: 48

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 17 Nov 2026several at once

    reported $240K of lobbying spend for the quarter ended 30 Sep 2026, 3.4× the same quarter last year, while it saw 84 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year. Two unrelated kinds of activity within 28 days.

    See the evidence (2 changes)

    Lobbying: Lobbying spend jump became public on 16 Oct 2026

    Glaukos reported $240K of lobbying spend for the quarter ended 30 Sep 2026, 3.4× the same quarter last year.

    This period
    $240K (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $85K
    Typical spread (median absolute deviation)
    $15K
    How far from its usual level
    +7.0
    Same quarter last year
    $70K
    History used
    4,475 days
    2024-09-30: $90K2024-12-31: $90K2025-03-31: $65K2025-06-30: $70K2025-09-30: $70K2025-12-31: $80K2026-03-31: $280K2026-06-30: $240K2026-09-30: $240K
    the quarter ended 30 Sep 20268 earlier quartersnormal: $85K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

    Institutional holdings: Many funds opening a new position became public on 16 Nov 2026

    Glaukos saw 84 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year.

    This period
    84 (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    48
    Typical spread (median absolute deviation)
    6
    How far from its usual level
    +4.0
    Same quarter last year
    55
    History used
    4,110 days
    2024-09-30: 472024-12-31: 392025-03-31: 492025-06-30: 432025-09-30: 552025-12-31: 522026-03-31: 412026-06-30: 652026-09-30: 84
    the quarter ended 30 Sep 20268 earlier quartersnormal: 48

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  2. 16 Nov 2026Institutional holdings change

    saw 84 13F filers open a new position in the quarter ended 30 Sep 2026, 1.5× the same quarter last year.

    Same quarter last year: 55; its normal quarter is 48.

    See the evidence
    This period
    84 (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    48
    Typical spread (median absolute deviation)
    6
    How far from its usual level
    +4.0
    Same quarter last year
    55
    History used
    4,110 days
    2024-09-30: 472024-12-31: 392025-03-31: 492025-06-30: 432025-09-30: 552025-12-31: 522026-03-31: 412026-06-30: 652026-09-30: 84
    the quarter ended 30 Sep 20268 earlier quartersnormal: 48

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  3. 16 Oct 2026Lobbying change

    reported $240K of lobbying spend for the quarter ended 30 Sep 2026, 3.4× the same quarter last year.

    Same quarter last year: $70K; its normal quarter is $85K.

    See the evidence
    This period
    $240K (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $85K
    Typical spread (median absolute deviation)
    $15K
    How far from its usual level
    +7.0
    Same quarter last year
    $70K
    History used
    4,475 days
    2024-09-30: $90K2024-12-31: $90K2025-03-31: $65K2025-06-30: $70K2025-09-30: $70K2025-12-31: $80K2026-03-31: $280K2026-06-30: $240K2026-09-30: $240K
    the quarter ended 30 Sep 20268 earlier quartersnormal: $85K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  4. 20 Jul 2026Lobbying change

    reported $240K of lobbying spend for the quarter ended 30 Jun 2026, 3.4× the same quarter last year.

    Same quarter last year: $70K; its normal quarter is $85K.

    See the evidence
    This period
    $240K (the quarter ended 30 Jun 2026)
    Normal quarter (median of 8 earlier)
    $85K
    Typical spread (median absolute deviation)
    $10K
    How far from its usual level
    +7.8
    Same quarter last year
    $70K
    History used
    4,383 days
    2024-06-30: $90K2024-09-30: $90K2024-12-31: $90K2025-03-31: $65K2025-06-30: $70K2025-09-30: $70K2025-12-31: $80K2026-03-31: $280K2026-06-30: $240K
    the quarter ended 30 Jun 20268 earlier quartersnormal: $85K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  5. 18 Apr 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['TAX']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    11163909
  6. 5 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 5 Jun 2024Filings record

    Director or officer change

  8. 18 Apr 2024Lobbying record

    GLAUKOS CORPORATION: new lobbying registration (in-house) (dated 1 Apr 2024)

  9. 10 Feb 2023Short interest and volume change

    had 4.4M shares sold short in the 31 Jan 2023 report, 2.5× the same report last year.

    Same report last year: 1.8M; its normal report is 1.9M.

    See the evidence
    This period
    4.4M (the 31 Jan 2023 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    350K
    How far from its usual level
    +4.9
    Same report last year
    1.8M
    History used
    1,859 days
    2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M2022-10-31: 4.2M2022-11-15: 4.1M2022-11-30: 4.1M2022-12-15: 4.2M2022-12-30: 4.4M2023-01-13: 4.5M2023-01-31: 4.4M
    the 31 Jan 2023 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 26 Jan 2023Short interest and volume change

    had 4.5M shares sold short in the 13 Jan 2023 report, 3.0× the same report last year.

    Same report last year: 1.5M; its normal report is 1.8M.

    See the evidence
    This period
    4.5M (the 13 Jan 2023 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    269K
    How far from its usual level
    +6.6
    Same report last year
    1.5M
    History used
    1,841 days
    2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M2022-10-31: 4.2M2022-11-15: 4.1M2022-11-30: 4.1M2022-12-15: 4.2M2022-12-30: 4.4M2023-01-13: 4.5M
    the 13 Jan 2023 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 12 Jan 2023Short interest and volume change

    had 4.4M shares sold short in the 30 Dec 2022 report, 3.7× the same report last year.

    Same report last year: 1.2M; its normal report is 1.8M.

    See the evidence
    This period
    4.4M (the 30 Dec 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    255K
    How far from its usual level
    +6.8
    Same report last year
    1.2M
    History used
    1,827 days
    2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M2022-10-31: 4.2M2022-11-15: 4.1M2022-11-30: 4.1M2022-12-15: 4.2M2022-12-30: 4.4M
    the 30 Dec 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 28 Dec 2022Short interest and volume change

    had 4.2M shares sold short in the 15 Dec 2022 report, 3.5× the same report last year.

    Same report last year: 1.2M; its normal report is 1.8M.

    See the evidence
    This period
    4.2M (the 15 Dec 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    255K
    How far from its usual level
    +6.2
    Same report last year
    1.2M
    History used
    1,812 days
    2021-11-30: 1.3M2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M2022-10-31: 4.2M2022-11-15: 4.1M2022-11-30: 4.1M2022-12-15: 4.2M
    the 15 Dec 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 10 Dec 2022Short interest and volume change

    had 4.1M shares sold short in the 30 Nov 2022 report, 3.1× the same report last year.

    Same report last year: 1.3M; its normal report is 1.8M.

    See the evidence
    This period
    4.1M (the 30 Nov 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    255K
    How far from its usual level
    +6.2
    Same report last year
    1.3M
    History used
    1,797 days
    2021-11-15: 1.5M2021-11-30: 1.3M2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M2022-10-31: 4.2M2022-11-15: 4.1M2022-11-30: 4.1M
    the 30 Nov 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 26 Nov 2022Short interest and volume change

    had 4.1M shares sold short in the 15 Nov 2022 report, 2.8× the same report last year.

    Same report last year: 1.5M; its normal report is 1.8M.

    See the evidence
    This period
    4.1M (the 15 Nov 2022 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    251K
    How far from its usual level
    +6.3
    Same report last year
    1.5M
    History used
    1,782 days
    2021-10-29: 1.4M2021-11-15: 1.5M2021-11-30: 1.3M2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M2022-10-31: 4.2M2022-11-15: 4.1M
    the 15 Nov 2022 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 10 Nov 2022Short interest and volume change

    had 4.2M shares sold short in the 31 Oct 2022 report, 2.9× the same report last year.

    Same report last year: 1.4M; its normal report is 1.7M.

    See the evidence
    This period
    4.2M (the 31 Oct 2022 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    214K
    How far from its usual level
    +7.8
    Same report last year
    1.4M
    History used
    1,767 days
    2021-10-15: 1.3M2021-10-29: 1.4M2021-11-15: 1.5M2021-11-30: 1.3M2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M2022-10-31: 4.2M
    the 31 Oct 2022 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 26 Oct 2022Short interest and volume change

    had 4.2M shares sold short in the 14 Oct 2022 report, 3.1× the same report last year.

    Same report last year: 1.3M; its normal report is 1.7M.

    See the evidence
    This period
    4.2M (the 14 Oct 2022 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    214K
    How far from its usual level
    +7.8
    Same report last year
    1.3M
    History used
    1,750 days
    2021-09-30: 2.0M2021-10-15: 1.3M2021-10-29: 1.4M2021-11-15: 1.5M2021-11-30: 1.3M2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M2022-10-14: 4.2M
    the 14 Oct 2022 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 13 Oct 2022Short interest and volume change

    had 3.9M shares sold short in the 30 Sep 2022 report, 2.0× the same report last year.

    Same report last year: 2.0M; its normal report is 1.7M.

    See the evidence
    This period
    3.9M (the 30 Sep 2022 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    214K
    How far from its usual level
    +7.1
    Same report last year
    2.0M
    History used
    1,736 days
    2021-09-15: 2.1M2021-09-30: 2.0M2021-10-15: 1.3M2021-10-29: 1.4M2021-11-15: 1.5M2021-11-30: 1.3M2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M2022-09-30: 3.9M
    the 30 Sep 2022 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 27 Sep 2022Short interest and volume change

    had 3.8M shares sold short in the 15 Sep 2022 report, 1.8× the same report last year.

    Same report last year: 2.1M; its normal report is 1.7M.

    See the evidence
    This period
    3.8M (the 15 Sep 2022 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    214K
    How far from its usual level
    +6.6
    Same report last year
    2.1M
    History used
    1,721 days
    2021-08-31: 2.3M2021-09-15: 2.1M2021-09-30: 2.0M2021-10-15: 1.3M2021-10-29: 1.4M2021-11-15: 1.5M2021-11-30: 1.3M2021-12-15: 1.2M2022-01-14: 1.5M2022-01-31: 1.8M2022-02-15: 1.8M2022-02-28: 1.8M2022-03-15: 1.8M2022-03-31: 1.5M2022-04-14: 2.1M2022-04-29: 2.0M2022-05-13: 1.8M2022-05-31: 1.6M2022-06-15: 1.6M2022-06-30: 1.9M2022-07-15: 1.6M2022-07-29: 1.6M2022-08-15: 1.6M2022-08-31: 2.5M2022-09-15: 3.8M
    the 15 Sep 2022 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 1 Mar 2022Financials change

    spent $9.3M on capital projects in the quarter ended 31 Dec 2021, 4.3× the same quarter last year.

    Same quarter last year: $2.1M; its normal quarter is $2.4M.

    See the evidence
    This period
    $9.3M (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    $2.4M
    Typical spread (median absolute deviation)
    $1.4M
    How far from its usual level
    +3.2
    Same quarter last year
    $2.1M
    History used
    2,649 days
    2019-12-31: $1.2M2020-03-31: $782K2020-06-30: $2.7M2020-09-30: $1.3M2020-12-31: $2.1M2021-03-31: $17.2M2021-06-30: $11.4M2021-09-30: $9.9M2021-12-31: $9.3M
    the quarter ended 31 Dec 20218 earlier quartersnormal: $2.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  20. 7 Feb 2022Filings record

    Director or officer change

  21. 20 Dec 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 20 Dec 2021Filings record

    Director or officer change

  23. 9 Nov 2021Financials change

    spent $9.9M on capital projects in the quarter ended 30 Sep 2021, 7.7× the same quarter last year.

    Same quarter last year: $1.3M; its normal quarter is $1.7M.

    See the evidence
    This period
    $9.9M (the quarter ended 30 Sep 2021)
    Normal quarter (median of 8 earlier)
    $1.7M
    Typical spread (median absolute deviation)
    $818K
    How far from its usual level
    +6.8
    Same quarter last year
    $1.3M
    History used
    2,557 days
    2019-09-30: $1.0M2019-12-31: $1.2M2020-03-31: $782K2020-06-30: $2.7M2020-09-30: $1.3M2020-12-31: $2.1M2021-03-31: $17.2M2021-06-30: $11.4M2021-09-30: $9.9M
    the quarter ended 30 Sep 20218 earlier quartersnormal: $1.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  24. 10 Aug 2021Financials change

    spent $11.4M on capital projects in the quarter ended 30 Jun 2021, 4.2× the same quarter last year.

    Same quarter last year: $2.7M; its normal quarter is $1.6M.

    See the evidence
    This period
    $11.4M (the quarter ended 30 Jun 2021)
    Normal quarter (median of 8 earlier)
    $1.6M
    Typical spread (median absolute deviation)
    $569K
    How far from its usual level
    +9.8
    Same quarter last year
    $2.7M
    History used
    2,465 days
    2019-06-30: $1.9M2019-09-30: $1.0M2019-12-31: $1.2M2020-03-31: $782K2020-06-30: $2.7M2020-09-30: $1.3M2020-12-31: $2.1M2021-03-31: $17.2M2021-06-30: $11.4M
    the quarter ended 30 Jun 20218 earlier quartersnormal: $1.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  25. 9 Jun 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 9 Jun 2021Filings record

    Director or officer change

  27. 11 May 2021Financials change

    spent $17.2M on capital projects in the quarter ended 31 Mar 2021, 22× the same quarter last year.

    Same quarter last year: $782K; its normal quarter is $1.2M.

    See the evidence
    This period
    $17.2M (the quarter ended 31 Mar 2021)
    Normal quarter (median of 8 earlier)
    $1.2M
    Typical spread (median absolute deviation)
    $521K
    How far from its usual level
    +15.9
    Same quarter last year
    $782K
    History used
    2,374 days
    2019-03-31: $651K2019-06-30: $1.9M2019-09-30: $1.0M2019-12-31: $1.2M2020-03-31: $782K2020-06-30: $2.7M2020-09-30: $1.3M2020-12-31: $2.1M2021-03-31: $17.2M
    the quarter ended 31 Mar 20218 earlier quartersnormal: $1.2M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  28. 1 Mar 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 1 Mar 2021Filings record

    Director or officer change

  30. 20 Oct 2020Lobbying record

    GLAUKOS CORPORATION: lobbying engagement terminated (THORN RUN PARTNERS) (dated 30 Sep 2020)

  31. 11 Aug 2020Financials change

    reported revenue of $31.6M for the quarter ended 30 Jun 2020, 46% below the same quarter last year.

    Same quarter last year: $58.6M; its normal quarter is $54.7M.

    See the evidence
    This period
    $31.6M (the quarter ended 30 Jun 2020)
    Normal quarter (median of 8 earlier)
    $54.7M
    Typical spread (median absolute deviation)
    $3.8M
    How far from its usual level
    -4.1
    Same quarter last year
    $58.6M
    History used
    2,283 days
    2018-06-30: $43.2M2018-09-30: $43.9M2018-12-31: $54.1M2019-03-31: $54.0M2019-06-30: $58.6M2019-09-30: $58.5M2019-12-31: $65.8M2020-03-31: $55.3M2020-06-30: $31.6M
    the quarter ended 30 Jun 20208 earlier quartersnormal: $54.7M

    Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 18 Mar 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 18 Mar 2020Filings record

    Director or officer change

  34. 21 Nov 2019Filings record

    Completed an acquisition or asset sale

  35. 12 Nov 2019Financials change

    reported revenue of $58.5M for the quarter ended 30 Sep 2019, 1.3× the same quarter last year.

    Same quarter last year: $43.9M; its normal quarter is $43.5M.

    See the evidence
    This period
    $58.5M (the quarter ended 30 Sep 2019)
    Normal quarter (median of 8 earlier)
    $43.5M
    Typical spread (median absolute deviation)
    $3.3M
    How far from its usual level
    +3.1
    Same quarter last year
    $43.9M
    History used
    2,009 days
    2017-09-30: $40.4M2017-12-31: $41.6M2018-03-31: $40.1M2018-06-30: $43.2M2018-09-30: $43.9M2018-12-31: $54.1M2019-03-31: $54.0M2019-06-30: $58.6M2019-09-30: $58.5M
    the quarter ended 30 Sep 20198 earlier quartersnormal: $43.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  36. 13 Aug 2019Financials change

    reported revenue of $58.6M for the quarter ended 30 Jun 2019, 1.4× the same quarter last year.

    Same quarter last year: $43.2M; its normal quarter is $42.4M.

    See the evidence
    This period
    $58.6M (the quarter ended 30 Jun 2019)
    Normal quarter (median of 8 earlier)
    $42.4M
    Typical spread (median absolute deviation)
    $1.7M
    How far from its usual level
    +3.8
    Same quarter last year
    $43.2M
    History used
    1,917 days
    2017-06-30: $41.3M2017-09-30: $40.4M2017-12-31: $41.6M2018-03-31: $40.1M2018-06-30: $43.2M2018-09-30: $43.9M2018-12-31: $54.1M2019-03-31: $54.0M2019-06-30: $58.6M
    the quarter ended 30 Jun 20198 earlier quartersnormal: $42.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  37. 8 Aug 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 8 Aug 2019Filings record

    Director or officer change (dated 7 Aug 2019)

  39. 14 May 2019Financials change

    reported revenue of $54.0M for the quarter ended 31 Mar 2019, 1.3× the same quarter last year.

    Same quarter last year: $40.1M; its normal quarter is $41.5M.

    See the evidence
    This period
    $54.0M (the quarter ended 31 Mar 2019)
    Normal quarter (median of 8 earlier)
    $41.5M
    Typical spread (median absolute deviation)
    $1.5M
    How far from its usual level
    +3.0
    Same quarter last year
    $40.1M
    History used
    1,826 days
    2017-03-31: $35.9M2017-06-30: $41.3M2017-09-30: $40.4M2017-12-31: $41.6M2018-03-31: $40.1M2018-06-30: $43.2M2018-09-30: $43.9M2018-12-31: $54.1M2019-03-31: $54.0M
    the quarter ended 31 Mar 20198 earlier quartersnormal: $41.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  40. 5 Mar 2019Financials change

    reported revenue of $54.1M for the quarter ended 31 Dec 2018, 1.3× the same quarter last year.

    Same quarter last year: $41.6M; its normal quarter is $40.8M.

    See the evidence
    This period
    $54.1M (the quarter ended 31 Dec 2018)
    Normal quarter (median of 8 earlier)
    $40.8M
    Typical spread (median absolute deviation)
    $1.6M
    How far from its usual level
    +3.2
    Same quarter last year
    $41.6M
    History used
    1,736 days
    2016-12-31: $33.2M2017-03-31: $35.9M2017-06-30: $41.3M2017-09-30: $40.4M2017-12-31: $41.6M2018-03-31: $40.1M2018-06-30: $43.2M2018-09-30: $43.9M2018-12-31: $54.1M
    the quarter ended 31 Dec 20188 earlier quartersnormal: $40.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

Showing the newest 40 of 59 entries; narrow the window or the kind of data to see older ones.

Not listed: 285 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001192448
Ticker
GKOS
Domain
glaukos.com
Employer name
Glaukos Corporation (1 unverified)
Hq location
CA|ALISO VIEJO|92656 (1 unverified)
Lobbying client
glaukos, glaukos corporation fka avedro
Name
Avedro, Inc, GKOS Medical, Unipessoal LDA, Glaukos Acquisition Corp, Glaukos Australia Pty Ltd and 15 more
Uei
M77LMBPAZLL9
  • DOL H-1B labor condition applications and PERM certifications82 data points2 Aug 2021 to 15 Jun 2026
  • Federal lobbying disclosures (LDA)9 records, 145 data points30 Jun 2007 to 30 Sep 2026
  • SEC Form 13F institutional holdings414 data points30 Jun 2015 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)127 records12 Jan 2016 to 28 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)877 data points31 Dec 2012 to 26 Oct 2026
  • SEC Form 4 insider transactions178 records, 576 data points4 Jan 2016 to 20 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards45 data points13 Jun 2024 to 21 Sep 2026